BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21543325)

  • 1. The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.
    Gerber SS; Lejon S; Locher M; Schaller J
    Cell Mol Life Sci; 2010 May; 67(9):1505-18. PubMed ID: 20112045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation and characterization of mice expressing a plasmin-inactivating active site mutation.
    Iwaki T; Malinverno C; Smith D; Xu Z; Liang Z; Ploplis VA; Castellino FJ
    J Thromb Haemost; 2010 Oct; 8(10):2341-4. PubMed ID: 20653841
    [No Abstract]   [Full Text] [Related]  

  • 3. Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology.
    Kangro K; Campbell RA; Tilvawala R; Flick MJ; Wolberg AS
    Res Pract Thromb Haemost; 2023 Aug; 7(6):102195. PubMed ID: 37736033
    [No Abstract]   [Full Text] [Related]  

  • 4. Contactless edema via plasmin.
    Strickland S; Norris EH
    Blood; 2024 Feb; 143(7):570-571. PubMed ID: 38358851
    [No Abstract]   [Full Text] [Related]  

  • 5. A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen.
    Quek AJ; Cowieson NP; Caradoc-Davies TT; Conroy PJ; Whisstock JC; Law RHP
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All tangled up: interactions of the fibrinolytic and innate immune systems.
    Whyte CS
    Front Med (Lausanne); 2023; 10():1212201. PubMed ID: 37332750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.
    Humphreys SJ; Whyte CS; Mutch NJ
    Front Cardiovasc Med; 2023; 10():1146833. PubMed ID: 37153474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.
    Alsayejh B; Kietsiriroje N; Almutairi M; Simmons K; Pechlivani N; Ponnambalam S; Ajjan RA
    TH Open; 2022 Oct; 6(4):e396-e407. PubMed ID: 36452200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.
    Pechlivani N; Kearney KJ; Ajjan RA
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Receptors and Fibrinolysis.
    Miles LA; Ny L; Wilczynska M; Shen Y; Ny T; Parmer RJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.
    Singh S; Saleem S; Reed GL
    Front Cardiovasc Med; 2020; 7():608899. PubMed ID: 33426005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α2-Antiplasmin as a potential regulator of the spatial memory process and age-related cognitive decline.
    Kawashita E; Ishihara K; Miyaji H; Tanishima Y; Kiriyama A; Matsuo O; Akiba S
    Mol Brain; 2020 Oct; 13(1):140. PubMed ID: 33059734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of the plasminogen receptor Plg-R
    Miles LA; Vago JP; Sousa LP; Parmer RJ
    J Thromb Haemost; 2020 Oct; 18(10):2468-2481. PubMed ID: 32662180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urokinase and consumption of α
    Longstaff C; Locke M
    J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rheumatoid Arthritis-Associated Citrullinome.
    Tilvawala R; Nguyen SH; Maurais AJ; Nemmara VV; Nagar M; Salinger AJ; Nagpal S; Weerapana E; Thompson PR
    Cell Chem Biol; 2018 Jun; 25(6):691-704.e6. PubMed ID: 29628436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered behavior in mice with deletion of the alpha2-antiplasmin gene.
    Kawashita E; Kanno Y; Ikeda K; Kuretake H; Matsuo O; Matsuno H
    PLoS One; 2014; 9(5):e97947. PubMed ID: 24874880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of differentially expressed serum proteins in infectious purpura fulminans.
    He T; Hu JY; Han J; Zhang DX; Jiang XP; Chen B; Huang YS
    Dis Markers; 2014; 2014():698383. PubMed ID: 24659849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
    Al-Horani RA; Desai UR
    Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
    Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
    J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.